Overview
- Fidji Simo announced she will leave her full‑time post and become a part‑time adviser to focus on recovery from a severe flare of a chronic neuroimmune condition.
- Simo had been on medical leave since April after a relapse of Postural Orthostatic Tachycardia Syndrome, a diagnosis she first disclosed in 2019.
- Company reporting says her product and commercial duties will be split among Greg Brockman, CFO Sarah Friar and CSO Jason Kwon, though those details come from media reports citing internal memos.
- The announcement came the same period OpenAI rolled out major product updates, including a new flagship model and an AI agent for ChatGPT, which shifts who will run the company’s product push.
- Investors and governance observers warn the loss of a widely seen No. 2 executive adds scrutiny to OpenAI’s IPO due diligence and raises questions about the company’s succession bench as it scales.